Research Article
Correlation between LRG1 and Adipokines in Psoriasis
Table 1
Clinical characteristics of patients with psoriasis and healthy controls.
| Variables | Psoriasis | Healthy control | |
| Gender | Male | 40 (74.07%) | 20 (76.92%) | > 0.05 | Female | 14 (25.93%) | 6 (23.08%) | Age (years) | 41.46 ± 14.45 | 48.81 ± 13.69 | = 0.033 | BMI | 30.08 (22.27, 32.25) | 22.51 (20.66, 23.95) | < 0.001 | Duration (years) | 10.00 (4.00, 17.25) | — | | PASI | 15.90 (11.10, 23.10) | — | | LRG1 (ng/mL) | 16.71 ± 3.88 | 9.74 ± 1.71 | < 0.001 | LRG1 (adjusted) | 13.25 ± 1.40 | 9.71 ± 2.19 | = 0.001 | Leptin (pg/mL) | 142.04 ± 27.46 | 49.07 ± 10.64 | < 0.001 | Leptin (adjusted) | 117.75 ± 11.60 | 47.16 ± 12.61 | < 0.001 | Resistin (pg/mL) | 382.50 ± 73.04 | 140.19 ± 18.94 | < 0.001 | Resistin (adjusted) | 320.95 ± 26.07 | 136.21 ± 20.87 | < 0.001 | Adiponectin (pg/mL) | 596.14 ± 137.99 | 945.03 ± 75.87 | < 0.001 | Adiponectin (adjusted) | 663.51 ± 92.88 | 967.75 ± 89.92 | < 0.001 |
|
|